Mg OSTEOCRETE Post-Treatment Outcomes

Recruiting Observational Study
Cancer of Bone Trauma Aseptic Loosening of Orthopaedic Hardware
No Placebo Group Every participant receives an active treatment — no one gets a placebo. No Study Drug Researchers observe your health over time — no experimental treatment is given.
Ready to participate?

Review the details below, then apply to join this clinical trial.

At a Glance
Age
18 and older
Sex
Any
Study type
Observational
Participants needed
10 (estimated)
Sponsor
Santiago Lozano-Calderon · Other
Think this trial could be right for you?

Answer a few quick questions to see if you may meet the eligibility requirements.

Check Your Eligibility
About This Trial

Mg OSTEOCRETE is a bone substitute used to fill a defect in bone caused by excision of a tumor, orthopaedic hardware that has become loosened, or a trauma-related condition. The aim of this study is to determine the amount of time it takes for bone to heal after treatment with Mg OSTEOCRETE, and to better understand the efficacy of this treatment through clinical and patient-reported outcomes.

Trial Locations
Loading…

Loading trial locations…

Eligibility Criteria
Inclusion Criteria: * 18 years of age and older on the day of surgery * has received or will receive Mg OSTEOCRETE as a component of their treatment at this institution in accordance with Instructions for Use for the implanted product * Mg OSTEOCRETE is indicated for one of the following reasons: …
Contacts

Shreya Halur, BS

617-726-4932

shalur@mgh.harvard.edu

CONTACT

Santiago A Lozano-Calderon, MD, PhD

617-643-4947

CONTACT